US Stocks
/
Larimar Therapeutics, Inc. Share Price

Larimar Therapeutics, Inc. Share Price

NASDAQ: LRMR | Micro Cap
$4.01
-$0.15 (-3.61%) Last updated on 11 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Larimar Therapeutics, Inc. Stock Performance

Open
$4.21
Prev. Close
$4.16
Circuit Range
N/A
Day Range
$4.05 - $4.29
Year Range
$2.72 - $6.42
Volume
1,54,339
Average Traded
$4.15

Larimar Therapeutics, Inc. Share Price Today

As of 11 August 2026, Larimar Therapeutics, Inc.'s share price is $4.01. The stock opened at $4.21, compared to its previous close of $4.16. During today's trading session, Larimar Therapeutics, Inc.'s share price traded between $4.05 and $4.29, with an average price of $4.17. Over the past 52 weeks, the stock has recorded a high of $6.42 and a low of $2.72. In terms of performance, Larimar Therapeutics, Inc.'s share price has declined by 24.48% over the last six months and is up 10.93% on a year-on-year basis.

Larimar Therapeutics, Inc. Share Price Chart

$4.05$4.29
L
Show Current Price
H

Larimar Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.00M
PE Ratio (TTM)
-3.37
Dividend Yield
N/A
EPS (TTM)
$-1.19
Revenue (TTM)
N/A
Return On Equity (TTM)
-212.17%
Profit Margin
N/A
Debt to Equity
0.83
Quarterly Earnings Growth YoY
-207.84%

Larimar Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$14.65M-$21.63M-$15.50M-$29.28M-$26.18M-$47.71M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-47.58%28.33%-88.92%10.58%-82.23%

Larimar Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$50.64M-$35.35M-$36.95M-$80.60M-$165.67M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A30.18%-4.51%-118.15%-105.54%

About Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Larimar Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$3.81
$4.16
+8.76%
Jul 2026
$3.07
$3.83
+25.82%
Jun 2026
$3.45
$3.04
-12.77%
May 2026
$4.03
$3.48
-14.14%
Apr 2026
$4.62
$4.06
-9.80%
Mar 2026
$5.00
$4.50
-15.25%
Feb 2026
$3.48
$5.31
+50.42%
Jan 2026
$3.71
$3.53
-7.47%
Dec 2025
$3.41
$3.81
+7.46%
Nov 2025
$3.95
$3.55
-8.97%
Oct 2025
$3.18
$3.90
+20.93%
Sep 2025
$3.91
$3.23
-10.79%

LRMR Share Price FAQs

What is Larimar Therapeutics, Inc. share price today?

chevron-up
Larimar Therapeutics, Inc. share price today is $4.01 as on August 11, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Larimar Therapeutics, Inc. stock?

chevron-up
The 52 week high of Larimar Therapeutics, Inc. stock is $6.42, while the 52 week low is $2.72 as of 11 Aug '26.

What is LRMR's market capitalisation today?

chevron-up
LRMR market capitalisation is $1.00M as of August 11, 2026, at 2:05 pm IST.

What is LRMR's net income for the last quarter?

chevron-up
LRMR's net income for the last quarter is -0.05B USD.

What is the 5 year returns of LRMR?

chevron-up
The 5 year returns of LRMR is -72.13% as on 11 Aug '26.

What is the high & low stock price of LRMR today?

chevron-up
LRMR stock price hit a high of $4.29 and low of $4.05 as of 11 Aug '26.

Can I buy LRMR shares in India?

chevron-up
Yes. You can buy LRMR in India by opening an international trading account.